Home/Filings/4/0001628280-24-008635
4//SEC Filing

Bergera J. Joseph 4

Accession 0001628280-24-008635

CIK 0000350868other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 6:05 PM ET

Size

23.1 KB

Accession

0001628280-24-008635

Insider Transaction Report

Form 4
Period: 2024-02-29
Bergera J. Joseph
President and CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-29$2.38/sh+14,000$33,320193,138 total
  • Sale

    Common Stock

    2024-02-29$5.19/sh10,714$55,564182,424 total
  • Exercise/Conversion

    Common Stock

    2024-03-01$2.38/sh+18,500$44,030200,924 total
  • Sale

    Common Stock

    2024-03-01$5.17/sh12,736$65,897188,188 total
  • Exercise/Conversion

    Common Stock

    2024-03-04$2.38/sh+4,323$10,289196,561 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-03-01$2.38/sh18,500$44,0301,117,500 total
    Exercise: $2.38Exp: 2025-09-22Common Stock (18,500 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-03-04$2.38/sh17,500$41,6501,100,000 total
    Exercise: $2.38Exp: 2025-09-22Common Stock (17,500 underlying)
  • Exercise/Conversion

    Common Stock

    2024-03-04$2.38/sh+17,500$41,650205,688 total
  • Sale

    Common Stock

    2024-03-04$5.03/sh13,450$67,633192,238 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-02-29$2.38/sh14,000$33,3201,136,000 total
    Exercise: $2.38Exp: 2025-09-22Common Stock (14,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-03-04$2.38/sh4,323$10,2891,095,677 total
    Exercise: $2.38Exp: 2025-09-22Common Stock (4,323 underlying)
Footnotes (5)
  • [F1]As disclosed in Iteris' Form 10-Q for the quarter ended December 31, 2023, pursuant to a Rule 10b5-1 plan adopted on November 30, 2023, the Reporting Person sold only enough shares to cover the exercise price and related taxes upon the Reporting Person's exercise of a portion of his stock options that expire in September 2025. The Reporting Person retained all of the remaining shares purchased upon exercise.
  • [F2]The reported securities were sold in multiple transactions at prices ranging from $5.11 to $5.24. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  • [F3]The reported securities were sold in multiple transactions at prices ranging from $5.06 to $5.24. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  • [F4]The reported securities were sold in multiple transactions at prices ranging from $5.00 to $5.15. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  • [F5]The option vested in full on September 22, 2019.

Issuer

ITERIS, INC.

CIK 0000350868

Entity typeother

Related Parties

1
  • filerCIK 0001653403

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:05 PM ET
Size
23.1 KB